Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Nevzorova, T. Brodskaya, T. Pestricova, O. Shekunova (Vladivostok, Russian Federation). Endothelin-1 level and central arterial stiffness in patients with COPD and hepatic cirrhosis. Eur Respir J 2008; 32: Suppl. 52, 3115

Member's Comments

No comment yet.

Related content which might interest you: Endothelin-1 level of functional tests and arterial deoxygenation in patients with COPD and cirrhosis Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 770 Year: 2009 Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Arterial stiffness and endothelial dysfunction in stable COPD patients Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension Source: Eur Respir J 2011; 37: 472 Year: 2011 To study pulmonary hemodynamics and the prevalence of porto pulmonary hypertension (POPH) in cirrhotic patients Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Apelin improves cardiac output in patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 The prevalence of pulmonary hypertension in cirrhotic patients submitted to hepatic transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 465s Year: 2003 Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009